C1 Inhibitor (Human) and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of C1 Inhibitor (Human) and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 Inhibitor (Human)-Tafenoquine Succinate (Arakoda)
- C1 Inhibitor (Human)-Tafenoquine Succinate (Krintafel)
- C1 Inhibitor (Human)-Tafinlar
- C1 Inhibitor (Human)-Tafluprost
- C1 Inhibitor (Human)-Tafluprost ophthalmic
- C1 Inhibitor (Human)-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-C1 Inhibitor (Human) (Berinert)
- Tafenoquine (Prevention of Malaria Relapse)-C1 Inhibitor (Human) (Cinryze)
- Tafenoquine (Prevention of Malaria Relapse)-C1 Inhibitor (Human) (Haegarda)
- Tafenoquine (Prevention of Malaria Relapse)-C1 Inhibitor (Recombinant)
- Tafenoquine (Prevention of Malaria Relapse)-C1-Esterase Inhibitor (Human)
- Tafenoquine (Prevention of Malaria Relapse)-C1-Esterase Inhibitor (Recombinant)